References
- Sevostyanova EV. Peculiarities of human lipid and carbohydrate metabolism in the North. Bûll sib med. 2013;12(1):93–7. doi: 10.20538/1682-0363-2013-1-
- Eslam M, Sanyal AJ, George J. International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated Fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.e1. doi: 10.1053/j.gastro.2019.11.312
- Bogomolov PO, KYu K, AYu M, et al. Genetic aspects of non-alcoholic fatty liver disease. Qu Modern Pediatr. 2018;17(6):442–448. doi: 10.15690/vsp.v17i6.1974
- Donati B, Motta BM, Pingitore P, et al. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage. Hepatology. 2016;63(3):787–798. doi: 10.1002/hep.28370
- Raikhelson KL, Kovyazina VP, Sidorenko DV, et al. Effect of PNPLA3 gene polymorphism on the course of non-alcoholic fatty liver disease. Russian Med J. 2019;12:85–88.
- Kurtanov K, Sydykova LA, Pavlova NI, et al. Polymorphism of the adiponutrin gene (PNPLA3) in the indigenous inhabitants of the Republic of Sakha (Yakutia) with type 2 diabetes mellitus. Almanac Clinical Med. 2018;46(3):258–263. doi: 10.18786/2072-0505-2018-46-3-258-263
- Site “1000 genomes” [Electronic resource]. http://www.internationalgenome.org/
- Site Haploview v. 4.2 [Electronic resource]. http://www.broadinstitute.org/scientific‐community/science/programs/medical‐and‐population‐genetics/haploview/haploview